New Insight Into A1 Adenosine Receptors in Diabetes Treatment

被引:8
|
作者
Wojcik, Marzena [1 ]
Zieleniak, Andrzej [1 ]
Wozniak, Lucyna A. [1 ]
机构
[1] Med Univ Lodz, Dept Biol Struct, PL-90752 Lodz, Poland
关键词
Adenosine receptors; agonists; antagonists; diabetes; insulin resistance; lipolysis; RAT B-LYMPHOCYTES; FREE FATTY-ACIDS; INSULIN-RESISTANCE; PARTIAL AGONIST; MEDICINAL CHEMISTRY; GLUCOSE-TOLERANCE; A(2B) RECEPTORS; ZUCKER RATS; IN-VIVO; PHARMACOLOGY;
D O I
10.2174/138161210794519066
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The A(1) adenosine receptors (A(1)AR), belonging to the rhodopsin-like superfamily of the G-protein-coupled receptors (GPCRs), may regulate many various cellular processes in cardiovascular, renal, and central nervous systems. In addition, since the A(1)AR possesses antilipolytic properties, numerous A(1)AR agonists and antagonists have been developed, but only some of them with the most promising selective properties in vitro have been advanced to animal studies and clinical trials. In this review, we have summarized the studies on the utility of A(1)AR selective agonists and antagonists in the regulation of lipid and carbohydrate metabolism and their potential therapeutic applications in diabetes.
引用
收藏
页码:4237 / 4242
页数:6
相关论文
共 50 条
  • [1] Flavonoids as antagonists at A1 adenosine receptors
    Alexander, Stephen P. H.
    PHYTOTHERAPY RESEARCH, 2006, 20 (11) : 1009 - 1012
  • [2] Adenosine A1 receptors and vascular reactivity
    Wang, Y.
    Yang, J. N.
    Arner, A.
    Boels, P. J. M.
    Fredholm, B. B.
    ACTA PHYSIOLOGICA, 2010, 199 (02) : 211 - 220
  • [3] Adenosine receptors and cardiovascular diseaseThe adenosine-1 receptor (A1) and A1 selective ligands
    E. S. Hayes
    Cardiovascular Toxicology, 2003, 3 (1) : 71 - 88
  • [4] Adenosine receptors and diabetes: Focus on the A2B adenosine receptor subtype
    Merighi, Stefania
    Borea, Pier Andrea
    Gessi, Stefania
    PHARMACOLOGICAL RESEARCH, 2015, 99 : 229 - 236
  • [5] Therapeutic potential of A1 adenosine receptor ligands:: a survey of recent patent literature
    Giorgi, Irene
    Nieri, Paola
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2008, 18 (07) : 677 - 691
  • [6] Feeding desensitizes A1 adenosine receptors in adipose through FOXO1-mediated transcriptional regulation
    Granade, Mitchell E.
    Hargett, Stefan R.
    Lank, Daniel S.
    Lemke, Michael C.
    Luse, Melissa A.
    Isakson, Brant E.
    Bochkis, Irina M.
    Linden, Joel
    Harris, Thurl E.
    MOLECULAR METABOLISM, 2022, 63
  • [7] Adenosine A1 receptors do not play a major role in the regulation of lipogenic gene expression in hepatocytes
    Yang, Ming
    Chu, Ruth
    Chisholm, Jeffrey W.
    Doege, Holger
    Belardinelli, Luiz
    Dhalla, Arvinder K.
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2012, 683 (1-3) : 332 - 339
  • [8] Roles of Adenosine A1 and A2A Receptors in the Control of Micturition in Rats
    Kitta, Takeya
    Chancellor, Michael B.
    de Groat, William C.
    Kuno, Sadako
    Nonomura, Katsuya
    Yoshimura, Naoki
    NEUROUROLOGY AND URODYNAMICS, 2014, 33 (08) : 1259 - 1265
  • [9] Therapeutic potentials of agonist and antagonist of adenosine receptors in type 2 diabetes
    Sanni, Olakunle
    Terre'Blanche, G.
    REVIEWS IN ENDOCRINE & METABOLIC DISORDERS, 2021, 22 (04): : 1073 - 1090
  • [10] A1 Receptors Ligands: Past, Present and Future Trends
    Schenone, S.
    Brullo, C.
    Musumeci, F.
    Bruno, O.
    Botta, M.
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2010, 10 (09) : 878 - 901